Literature DB >> 10558872

Differentiation-induced insulin secretion from nonendocrine cells with engineered human proinsulin cDNA.

K Yamasaki1, T Sasaki, M Nemoto, Y Eto, N Tajima.   

Abstract

To investigate the effects of differentiation on insulin secretion from engineered nonendocrine cells, modified human proinsulin cDNA (INS/fur) was transfected to THP-1 monocyte and C2C12 myoblast cell lines. When THP-1 was differentiated into macrophages with phorbol ester, the insulin secretion rate was increased by 3.1-fold. This increase in insulin secretion is accompanied by a 17.6-fold increase in the processing efficiency of the modified human proinsulin and by a 3.5-fold increase in the abundance of furin mRNA. In addition, differentiation of C2C12 into myotubes, which can be induced by changing the serum, showed a 9.9-fold increase in insulin secretion and was accompanied by a 1.6-fold increase in the abundance of furin mRNA. The involvement of posttranslational processing and the exocytotic process in differentiation-induced insulin secretion could lead to the possibility of regulation of insulin secretion from genetically engineered cells. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10558872     DOI: 10.1006/bbrc.1999.1698

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  Gene and cell-based therapy for diabetes mellitus: endocrine gene therapeutics.

Authors:  Takashi Sasaki; Kei Fujimoto; Kyoko Sakai; Masami Nemoto; Nozomu Nakai; Naoko Tajima
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

2.  Enhanced insulin secretion from engineered 3T3-L1 preadipocytes by induction of cellular differentiation.

Authors:  Kei Fujimoto; Takashi Sasaki; Masami Nemoto; Nozomu Nakai; Kyoko Sakai; Koichiro Yamasaki; Yoshito Hiki; Toya Ohashi; Yoshikatsu Eto; Naoko Tajima
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

3.  Establishment of an artificial beta-cell line expressing insulin under the control of doxycycline.

Authors:  Xin-Yu Qin; Kun-Tang Shen; Xin Zhang; Zhi-Hong Cheng; Xiang-Ru Xu; Ze-Guang Han
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

4.  Construction of a recombinant human insulin expression vector for mammary gland-specific expression in buffalo (Bubalus bubalis) mammary epithelial cell line.

Authors:  Ramakant Kaushik; Karn Pratap Singh; Archana Kumari; K Rameshbabu; Manoj Kumar Singh; Radhey Shyam Manik; Prabhat Palta; Suresh Kumar Singla; Manmohan Singh Chauhan
Journal:  Mol Biol Rep       Date:  2014-06-27       Impact factor: 2.316

5.  Simvastatin suppresses the differentiation of C2C12 myoblast cells via a Rac pathway.

Authors:  Tomomi T Baba; Takayuki K Nemoto; Toshihiro Miyazaki; Shinichiro Oida
Journal:  J Muscle Res Cell Motil       Date:  2008-09-16       Impact factor: 2.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.